Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis

Kevin Pethe*, Pablo Bifani, Jichan Jang, Sunhee Kang, Seijin Park, Sujin Ahn, Jan Jiricek, Juyoung Jung, Hee Kyoung Jeon, Jonathan Cechetto, Thierry Christophe, Honggun Lee, Marie Kempf, Mary Jackson, Anne J. Lenaerts, Ha Pham, Victoria Jones, Min Jung Seo, Young Mi Kim, Mooyoung SeoJeong Jea Seo, Dongsik Park, Yoonae Ko, Inhee Choi, Ryangyeo Kim, Se Yeon Kim, Seungbin Lim, Seung Ae Yim, Jiyoun Nam, Hwankyu Kang, Haejin Kwon, Chun Taek Oh, Yoojin Cho, Yunhee Jang, Junghwan Kim, Adeline Chua, Bee Huat Tan, Mahesh B. Nanjundappa, Srinivasa P.S. Rao, Whitney S. Barnes, René Wintjens, John R. Walker, Sylvie Alonso, Saeyeon Lee, Jungjun Kim, Soohyun Oh, Taegwon Oh, Ulf Nehrbass, Sung Jun Han, Zaesung No, Jinhwa Lee, Priscille Brodin, Sang Nae Cho, Kiyean Nam, Jaeseung Kim

*Corresponding author for this work

Research output: Contribution to journal › Article › Research › peer-review

505 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science